Therapeutic Asset Ratings
3,232 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Durvalumab
Non-Small Cell Lung Carcinoma
University of Chicago
P4
BB
(69)
Empagliflozin
Dumping Syndrome
Insel Gruppe AG, University Hospital Bern
P4
BB
(69)
Empagliflozin
Glucose Metabolism Disease
SINA Health Education and Welfare Trust
P4
BB
(69)
Empagliflozin
Hypoglycemia
Insel Gruppe AG, University Hospital Bern
P4
BB
(69)
Empagliflozin
Amyloidosis
Columbia University
P4
BB
(69)
Epirubicin
Breast Neoplasm
Universitas Airlangga
P4
BB
(69)
Eribulin
Breast Cancer
Sun Yat-sen University
P4
BB
(69)
ERIBULIN MONOMETHANESULFONATE
Breast Cancer
Henan Cancer Hospital
P4
BB
(69)
ERIBULIN MONOMETHANESULFONATE
Breast Neoplasm
Fudan University
P4
BB
(69)
ETOMIDATE
Bipolar Disorder
Yeongseok Yun
P4
BB
(69)
ETOMIDATE
Major Depressive Disorder
Yeongseok Yun
P4
BB
(69)
ETOMIDATE
Schizophrenia
Yeongseok Yun
P4
BB
(69)
Everolimus
Renal Cell Carcinoma
Merck Sharp & Dohme LLC
P4
BB
(69)
Exenatide
Obesity Disorder
Vivani Medical, Inc
P4
BB
(69)
FENTANYL
Migraine Disorder
Washington University School of Medicine
P4
BB
(69)
FENTANYL
Traumatic Brain Injury
Henry M. Jackson Foundation for the Advancement of Military Medicine
P4
BB
(69)
Fexofenadine
Fabry Disease
Sanofi
P4
BB
(69)
FILGRASTIM
Plasma Cell Myeloma
Janssen Research & Development, LLC
P4
BB
(69)
Fluconazole
Candidiasis, Invasive
Radboud University Medical Center
P4
BB
(69)
FLUOROURACILUM
Gastric Cancer
I-Mab Biopharma US Limited
P4
BB
(69)
FLUOROURACILUM
Intraepithelial Neoplasia
Rutgers, The State University of New Jersey
P4
BB
(69)
Folic Acid
Hypertensive Disorder
Shenzhen Ausa Pharmed Co.,Ltd
P4
BB
(69)
Foscarnet
Cytomegalovirus Infection
City of Hope Medical Center
P4
BB
(69)
FULVESTRANT
Breast Cancer
MedSIR
P4
BB
(69)
fx-1006a
Amyloidosis
Pfizer
P4
BB
(69)
Showing 1051 to 1075 of 3,232 assets
Previous
Page 43 of 130
Next